Differing Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Ipragliflozin on the Decrease of Fat Mass vs. Lean Mass in Patients With or Without Metformin Therapy
2019 ◽
Vol 11
(4)
◽
pp. 297-300
◽
Keyword(s):
Fat Mass
◽
2014 ◽
Vol 233
(1)
◽
pp. 310-318
◽